|
19 May 2007 |
KV Pharmaceutical Company (KVA) Announces Approval for Two Strengths of Generic Versions of Toprol-XL(R)
|
|
18 May 2007 |
Roche and Siena Biotech S.p.A. Enter Research Collaboration Agreement in Neurodegenerative Diseases
|
|
17 May 2007 |
Next Generation Nasal Spray Against Influenza: Clinical Phase I Study Started With FLUVACCdelNS1
|
|
17 May 2007 |
Organon and Medarex announce biotherapeutics development agreement
|
|
17 May 2007 |
Glenmark receives US FDA approval to market generic
|
|
17 May 2007 |
CollaGenex Pharmaceuticals and QuatRx Pharmaceuticals Announce Agreement for the Development and Commercialization of Becocalcidiol
|
|
17 May 2007 |
Ranbaxy Receives Tentative FDA Approval for Fexofenadine Hydrochloride Tablets
|
|
16 May 2007 |
Proteros Biostructures and Boehringer Ingelheim Pharmaceuticals Enter into Protein Crystallography Agreement
|
|
16 May 2007 |
Lupin Pharmaceuticals, Inc. Receives US FDA Approval for Simvastatin Tablets
|
|
15 May 2007 |
Skyepharma PLC and Sciele Pharma Announce Successful Completion of New Sular(R) Formulation Clinical Trial Programme
|
|
15 May 2007 |
BDSI Announces Positive Key Secondary Efficacy Endpoint Results for Bema Fentanyl
|
|
15 May 2007 |
GSK Returns Development Rights for MED2002
|
|
13 May 2007 |
Mylan Laboratories to Acquire Generics Business of Merck KGaA
|
|
12 May 2007 |
DermTech and UCSF Collaborate to Explore Potential of Company's EGIR Technology to Develop Novel Compounds for Anti-aging and Atopic Dermatitis
|
|
11 May 2007 |
FDA Approves Schwarz Pharma's Neupro (Rotigotine Transdermal System) for the Treatment of Early-Stage Parkinson's Disease in USA
|
|
11 May 2007 |
Teva Announces Approval and Shipment of Generic Omnicef(R) Capsules and POS
|
|
11 May 2007 |
Viropro Inc. and Intas Biopharmaceuticals Announce the Signature of a Binding MOU for the Development and Production of a Therapeutic Protein
|
|
11 May 2007 |
Gene Logic and Abbott Enter Collaboration to Discover New Development Paths for Multiple Clinical Drug Candidates
|
|
10 May 2007 |
Bristol-Myers Squibb Enters Cardiovascular Disease Collaboration With Isis Pharmaceuticals
|
|
09 May 2007 |
Focetria(R), the Novartis pandemic influenza vaccine, receives European Union approval
|
|
09 May 2007 |
Oramed Pharmaceuticals Begins Phase 1 Human Clinical Trials
|
|
09 May 2007 |
4SC AG Provides Proof of Concept for Drug Candidate SC75741 in the Treatment of Influenza A-infected Mice
|
|
09 May 2007 |
Inspire Announces Positive Results of Phase 2 Trial of Epinastine Nasal Spray for Seasonal Allergic Rhinitis
|
|
09 May 2007 |
Lupin Pharmaceuticals, Inc. Announces Final FDA Approval of Cefdinir for Oral Suspension, 250 mg/5 mL, Launches Entire Product Family
|
|
09 May 2007 |
Entelos and Jubilant Announce Alliance to Develop Therapeutics and Offer Joint Services
|
